Dll1 Haploinsufficiency in Adult Mice Leads to a Complex Phenotype Affecting Metabolic and Immunological Processes

Background The Notch signaling pathway is an evolutionary conserved signal transduction pathway involved in embryonic patterning and regulation of cell fates during development and self-renewal. Recent studies have demonstrated that this pathway is integral to a complex system of interactions, involving as well other signal transduction pathways, and implicated in distinct human diseases. Delta-like 1 (Dll1) is one of the known ligands of the Notch receptors. The role of the Notch ligands is less well understood. Loss-of-function of Dll1 leads to embryonic lethality, but reduction of Delta-like 1 protein levels has not been studied in adult stage. Methodology/Principal Findings Here we present the haploinsufficient phenotype of Dll1 and a missense mutant Dll1 allele (Dll1C413Y). Haploinsufficiency leads to a complex phenotype with several biological processes altered. These alterations reveal the importance of Dll1 mainly in metabolism, energy balance and in immunology. The animals are smaller, lighter, with altered fat to lean ratio and have increased blood pressure and a slight bradycardia. The animals have reduced cholesterol and triglyceride levels in blood. At the immunological level a subtle phenotype is observed due to the effect and fine-tuning of the signaling network at the different levels of differentiation, proliferation and function of lymphocytes. Moreover, the importance of the proteolytic regulation of the Notch signaling network emphasized. Conclusions/Significance In conclusion, slight alterations in one player of Notch signaling alter the entire organism, emphasizing the fine-tuning character of this pathway in a high number of processes.

[1]  D. Selkoe,et al.  Direct and Potent Regulation of γ-Secretase by Its Lipid Microenvironment* , 2008, Journal of Biological Chemistry.

[2]  S. Tsaih,et al.  Genetic influence on immune phenotype revealed strain-specific variations in peripheral blood lineages. , 2008, Physiological genomics.

[3]  E. Gelfand,et al.  Essential role of Notch signaling in effector memory CD8+ T cell–mediated airway hyperresponsiveness and inflammation , 2008, The Journal of experimental medicine.

[4]  L. Chao,et al.  Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress , 2008, Hypertension.

[5]  H. Fuchs,et al.  "Sighted C3H" mice--a tool for analysing the influence of vision on mouse behaviour? , 2008, Frontiers in bioscience : a journal and virtual library.

[6]  E. Canalis,et al.  Notch Signaling in Osteoblasts , 2008, Science Signaling.

[7]  D. Busch,et al.  Mouse Phenotyping: Immunology , 2008 .

[8]  H. Fuchs,et al.  Systematic gene expression profiling of mouse model series reveals coexpressed genes , 2008, Proteomics.

[9]  A. Martinez Arias,et al.  Wnt/Notch signalling and information processing during development , 2008, Development.

[10]  P. Mazur,et al.  Notch signaling is required for exocrine regeneration after acute pancreatitis. , 2008, Gastroenterology.

[11]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[12]  M. Ciofani,et al.  The thymus as an inductive site for T lymphopoiesis. , 2007, Annual review of cell and developmental biology.

[13]  Alfonso Martinez Arias,et al.  Cell and molecular biology of Notch. , 2007, The Journal of endocrinology.

[14]  G. Churchill,et al.  Genetic Background Modifies Inner Ear and Eye Phenotypes of Jag1 Heterozygous Mice , 2007, Genetics.

[15]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[16]  G. Weinmaster,et al.  Notch Signaling – Constantly on the Move , 2007, Traffic.

[17]  T. Gridley Notch signaling in vascular development and physiology , 2007, Development.

[18]  M. Iruela-Arispe,et al.  Notch signaling in blood vessels: who is talking to whom about what? , 2007, Circulation research.

[19]  Yun-Cai Liu The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance. , 2007, Seminars in immunology.

[20]  T. Honjo,et al.  Regulation of lymphocyte development by Notch signaling , 2007, Nature Immunology.

[21]  Raphael Kopan,et al.  SnapShot: Notch Signaling Pathway , 2007, Cell.

[22]  Gerhard K. H. Przemeck,et al.  A Genetic Screen for Modifiers of the Delta1-Dependent Notch Signaling Function in the Mouse , 2007, Genetics.

[23]  M. Augustin,et al.  Expanding the body mass range: associations between BMR and tissue morphology in wild type and mutant dwarf mice (David mice) , 2007, Journal of Comparative Physiology B.

[24]  Martin Klingenspor,et al.  Power matters in closing the phenotyping gap , 2007, Naturwissenschaften.

[25]  N. Copeland,et al.  Itch genetically interacts with Notch1 in a mouse autoimmune disease model. , 2006, Human molecular genetics.

[26]  G. Karsenty,et al.  Convergence between bone and energy homeostases: leptin regulation of bone mass. , 2006, Cell metabolism.

[27]  H. Fuchs,et al.  Metabolic phenotyping of mouse mutants in the German Mouse Clinic. , 2006, Integrative zoology.

[28]  R. Leker Manipulation of Endogenous Neural Stem Cells Following Ischemic Brain Injury , 2006, Pathophysiology of Haemostasis and Thrombosis.

[29]  Adrian L Harris,et al.  Hypoxia-regulated differentiation: let's step it up a Notch. , 2006, Trends in molecular medicine.

[30]  Bogdan Tanasa,et al.  Regulation of Th2 differentiation and Il4 locus accessibility. , 2006, Annual review of immunology.

[31]  E. Wolf,et al.  Genotype-specific environmental impact on the variance of blood values in inbred and F1 hybrid mice , 2006, Mammalian Genome.

[32]  A. Harder,et al.  Identification of Dll1 (Delta1) target genes during mouse embryogenesis using differential expression profiling. , 2005, Gene expression patterns : GEP.

[33]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[34]  P Chambon,et al.  EMPReSS: standardized phenotype screens for functional annotation of the mouse genome , 2005, Nature Genetics.

[35]  F. Gounari,et al.  Loss of adenomatous polyposis coli gene function disrupts thymic development , 2005, Nature Immunology.

[36]  Werner Müller,et al.  Introducing the German Mouse Clinic: open access platform for standardized phenotyping , 2005, Nature Methods.

[37]  M. Mayhaus,et al.  Efficient and fast targeted production of murine models based on ENU mutagenesis , 2005, Mammalian Genome.

[38]  K. Makar,et al.  DNA methylation and the expanding epigenetics of T cell lineage commitment. , 2005, Seminars in immunology.

[39]  G. Boers,et al.  Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuria. , 2005, Journal of molecular biology.

[40]  T. Kadesch,et al.  Notch signaling: the demise of elegant simplicity. , 2004, Current opinion in genetics & development.

[41]  J. Pérez-Castrillón,et al.  Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.

[42]  M. Bursztyn Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.

[43]  Jianzhu Chen,et al.  The T-Cell Receptor β Variable Gene Promoter Is Required for Efficient Vβ Rearrangement but Not Allelic Exclusion , 2004, Molecular and Cellular Biology.

[44]  R. Hegele,et al.  Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration , 2004, Clinical genetics.

[45]  N. Tamaoki,et al.  Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo , 2004, Nature Immunology.

[46]  A. Hofman,et al.  Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.

[47]  W. Alexander,et al.  Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Bell,et al.  Expression of Notch‐1 and its ligand Jagged‐1 in rat liver during liver regeneration , 2004, Hepatology.

[49]  A. Gossler,et al.  Specification of vertebral identity is coupled to Notch signalling and the segmentation clock , 2004, Development.

[50]  C. Guidos,et al.  Notch signaling in development and disease , 2003, Clinical genetics.

[51]  J. Choi,et al.  Bone mineral density correlates strongly with basal metabolic rate in postmenopausal women. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[52]  Yusuke Nakamura,et al.  Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. , 2003, Cancer research.

[53]  S. Artavanis-Tsakonas,et al.  Delta-Notch signaling controls the generation of neurons/glia from neural stem cells in a stepwise process , 2003, Development.

[54]  P. Coughlin,et al.  A review and comparison of the murine α1-antitrypsin and α1-antichymotrypsin multigene clusters with the human clade A serpins , 2003 .

[55]  R. Hegele,et al.  Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH) , 2003, Human Genetics.

[56]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[57]  B. de Strooper,et al.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. , 2002, Human molecular genetics.

[58]  S. Klahr,et al.  Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. , 2002, Journal of the American Society of Nephrology : JASN.

[59]  M. Malavolti,et al.  Relationship between body composition and bone mineral content in young and elderly women , 2002, Annals of human biology.

[60]  A. Israël,et al.  Siah-1 binds and regulates the function of Numb , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[62]  L. Chao,et al.  Novel Roles of Kallistatin, a Specific Tissue Kallikrein Inhibitor, in Vascular Remodeling , 2001, Biological chemistry.

[63]  A. Weissman,et al.  RING Finger Proteins Mediators of Ubiquitin Ligase Activity , 2000, Cell.

[64]  N. Lee,et al.  A concise guide to cDNA microarray analysis. , 2000, BioTechniques.

[65]  Klaus Schughart,et al.  Genome-wide, large-scale production of mutant mice by ENU mutagenesis , 2000, Nature Genetics.

[66]  H. Fuchs,et al.  Screening for dysmorphological abnormalities—a powerful tool to isolate new mouse mutants , 2000, Mammalian Genome.

[67]  Andreas Teubner,et al.  The large-scale Munich ENU-mouse-mutagenesis screen , 2000, Mammalian Genome.

[68]  D. Kiel,et al.  Risk Factors for Longitudinal Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  G. Weinmaster,et al.  Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. , 1999, Human molecular genetics.

[70]  E. Fearon,et al.  Siah-1 N-Terminal RING Domain Is Required for Proteolysis Function, and C-Terminal Sequences Regulate Oligomerization and Binding to Target Proteins , 1999, Molecular and Cellular Biology.

[71]  M. Scheffner,et al.  Characterization of Human hect Domain Family Members and Their Interaction with UbcH5 and UbcH7* , 1998, The Journal of Biological Chemistry.

[72]  John Calvin Reed,et al.  p53‐inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG‐1 , 1998, The EMBO journal.

[73]  G. Weinmaster,et al.  Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. , 1998, Genes & development.

[74]  H. Frost Obesity, and bone strength and "mass": a tutorial based on insights from a new paradigm. , 1997, Bone.

[75]  M. H. Angelis,et al.  Maintenance of somite borders in mice requires the Delta homologue Dll1 , 1997, Nature.

[76]  M. Aickin,et al.  Fat or Lean Tissue Mass: Which One Is the Major Determinant of Bone Mineral Mass in Healthy Postmenopausal Women? , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[77]  U. Lendahl,et al.  Expression of the Notch 3 intracellular domain in mouse central nervous system progenitor cells is lethal and leads to disturbed neural tube development , 1996, Mechanisms of Development.

[78]  A. Chambers,et al.  Human isopentenyl diphosphate: dimethylallyl diphosphate isomerase: overproduction, purification, and characterization. , 1996, Archives of biochemistry and biophysics.

[79]  D. Simon,et al.  Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta. , 1995, Development.

[80]  R. Brent,et al.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. , 1995, Molecular endocrinology.

[81]  A. Avenell,et al.  Bone loss associated with a high fibre weight reduction diet in postmenopausal women. , 1994, European journal of clinical nutrition.

[82]  G. Weinmaster,et al.  Notch1 is essential for postimplantation development in mice. , 1994, Genes & development.

[83]  T. Mak,et al.  CD8 is needed for development of cytotoxic T but not helper T cells , 1991, Cell.

[84]  P. Edwards,et al.  Isolation and sequence of the human farnesyl pyrophosphate synthetase cDNA. Coordinate regulation of the mRNAs for farnesyl pyrophosphate synthetase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and 3-hydroxy-3-methylglutaryl coenzyme A synthase by phorbol ester. , 1990, The Journal of biological chemistry.

[85]  C. D. Ankney,et al.  The effect of apparatus, extraction time, and solvent type on lipid extractions of snow geese , 1985 .

[86]  Jonathan A. Epstein,et al.  The multifaceted role of Notch in cardiac development and disease , 2008, Nature Reviews Genetics.

[87]  H. Fuchs,et al.  Phenotypic characterization of mouse models for bone-related diseases in the German Mouse Clinic. , 2008, Journal of musculoskeletal & neuronal interactions.

[88]  小林 隆彦 Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury , 2008 .

[89]  John Calvin Reed,et al.  Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpoint. , 2006, Immunity.

[90]  Raymond J. Deshaies,et al.  Function and regulation of cullin–RING ubiquitin ligases , 2005, Nature Reviews Molecular Cell Biology.

[91]  Jianzhu Chen,et al.  The T-cell receptor beta variable gene promoter is required for efficient V beta rearrangement but not allelic exclusion. , 2004, Molecular and cellular biology.

[92]  S. Aizawa,et al.  Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. , 2003, Nature immunology.

[93]  P. Coughlin,et al.  A review and comparison of the murine alpha1-antitrypsin and alpha1-antichymotrypsin multigene clusters with the human clade A serpins. , 2003, Genomics.

[94]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[95]  T. Mak,et al.  CD8 is needed for development of cytotoxic T cells but not helper T cells. , 1991, Cell.